Josep Garcia

8PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 16, 2026
Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.

Francesco Sanvito, Catalina Raymond, Donatello Telesca

|Feb 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Jan 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Aug 04, 2023
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma.

Benjamin M Ellingson, Akifumi Hagiwara, Connor J Morris

|Apr 12, 2022
MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial.

Daniel Rodriguez, Raphael Calmon, Esther Sanchez Aliaga

|Jan 12, 2020
Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial.

Daniel Rodriguez Gutierrez, Chris Jones, Pascale Varlet

Pageof 2

Frequent Collaborators

4 joint publications

Timothy Jaspan

4 joint publications

Paul S Morgan

4 joint publications

Jacques Grill

4 joint publications

Darren R Hargrave